Zobraziť v EDS

One-year clinical outcomes of ticagrelor compared with clopidogrel after percutaneous coronary intervention in patients with acute myocardial infarction: From Korean Health Insurance Review and Assessment Data

Uložené v:
Podrobná bibliografia
Názov: One-year clinical outcomes of ticagrelor compared with clopidogrel after percutaneous coronary intervention in patients with acute myocardial infarction: From Korean Health Insurance Review and Assessment Data
Autori: Choongki Kim, Dong-Ho Shin, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Juhee Park, Hyeyeong Lee, Dong-Sook Kim, Sang-Kwon Oh, Yangsoo Jang
Prispievatelia: Choongki Kim, Dong-Ho Shin, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Juhee Park, Hyeyeong Lee, Dong-Sook Kim, Sang-Kwon Oh, Yangsoo Jang, Ko, Young Guk
Zdroj: Journal of Cardiology. 73:191-197
Informácie o vydavateľovi: Elsevier BV, 2019.
Rok vydania: 2019
Predmety: Male, Ticagrelor, Clopidogrel / administration & dosage, Myocardial Infarction, Ticagrelor / adverse effects, Hemorrhage, Platelet Aggregation Inhibitors / administration & dosage, Coronary artery disease, Insurance, 03 medical and health sciences, Percutaneous Coronary Intervention, 0302 clinical medicine, Ticagrelor / administration & dosage, Cause of Death, Republic of Korea, Odds Ratio, Humans, Republic of Korea / epidemiology, Aged, Insurance, Health, Stroke / etiology, Drug Substitution, Incidence, Stroke / epidemiology, Clopidogrel / adverse effects, Platelet Aggregation Inhibitors / adverse effects, Platelet inhibitors, Middle Aged, Combined Modality Therapy, Myocardial Infarction / mortality, Clopidogrel, 3. Good health, Treatment, Stroke, Myocardial infarction, Treatment Outcome, Health, Hemorrhage / chemically induced, Myocardial Infarction / complications, Female, Myocardial Infarction / therapy, Platelet Aggregation Inhibitors
Popis: Ticagrelor has been widely accepted in clinical practice for treatment of acute myocardial infarction (AMI), however its clinical safety and efficacy have not been revealed sufficiently in Asian populations.Among a total 20,270 patients (age
Druh dokumentu: Article
Jazyk: English
ISSN: 0914-5087
DOI: 10.1016/j.jjcc.2018.08.005
Prístupová URL adresa: http://www.journal-of-cardiology.com/article/S0914508718302648/pdf
https://pubmed.ncbi.nlm.nih.gov/30770037
https://yonsei.pure.elsevier.com/en/publications/one-year-clinical-outcomes-of-ticagrelor-compared-with-clopidogre
https://pubmed.ncbi.nlm.nih.gov/30770037/
https://www.ncbi.nlm.nih.gov/pubmed/30770037
https://www.sciencedirect.com/science/article/pii/S0914508718302648
Rights: Elsevier Non-Commercial
CC BY NC ND
Prístupové číslo: edsair.doi.dedup.....71fca71588e1b12af3f9ab86bee06baf
Databáza: OpenAIRE
Popis
Abstrakt:Ticagrelor has been widely accepted in clinical practice for treatment of acute myocardial infarction (AMI), however its clinical safety and efficacy have not been revealed sufficiently in Asian populations.Among a total 20,270 patients (age
ISSN:09145087
DOI:10.1016/j.jjcc.2018.08.005